Premium
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra‐patient, prospective, comparison study in Italy
Author(s) -
Fargnoli M.C.,
Piccioni A.,
Neri L.,
Tambone S.,
Pellegrini C.,
Peris K.
Publication year - 2015
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.13076
Subject(s) - medicine , actinic keratosis , tolerability , scalp , photodynamic therapy , dermatology , keratosis , daylight , prospective cohort study , adverse effect , surgery , organic chemistry , basal cell , optics , chemistry , physics
Daylight photodynamic therapy ( DL ‐ PDT ) with methyl aminolevulinate ( MAL ) is a simplified PDT procedure that was recently shown in a few trials to be effective for grade I actinic keratosis ( AK ), with improved tolerability and reduced time of clinical attendance as compared to conventional PDT (c‐ PDT ). Objective To evaluate the efficacy and tolerability of DL ‐ PDT vs. c‐ PDT with MAL in the treatment of grade I AK on the face and scalp in Italy. Methods Thirty‐five patients with AK s on the face ( n = 17) or scalp ( n = 18) were prospectively enrolled in an intra‐patient, left‐right, prospective, comparison study between DL ‐ PDT and c‐ PDT at a single centre between September and October 2013. Weather conditions and outdoor temperature during daylight exposure were recorded for each DL ‐ PDT session. Pain was assessed after the PDT session and local adverse events 2 days after treatment. Lesion response rate was evaluated on both sides at 3 months. AK s with complete regression were followed until 6 months. Patient's preference for either treatment was recorded. Results There was no difference in complete response ( CR ) rate of AK I at 3 months between DL ‐ PDT and c‐ PDT (87% vs. 91%; RR = 0.96; P = 0.16). A lower CR rate was observed with DL ‐ PDT than with c‐ PDT for AK II (36% vs. 61%; RR = 0.58, P = 0.06) and III (25% vs. 46%; RR = 0.50, P = 0.20). Recurrence rate at 6 months was slightly higher for cleared AK I after DL ‐ PDT than after c‐ PDT (17% vs. 12%, RR = 1.50, P < 0.05). DL ‐ PDT was associated with lower pain (Δ VAS = −2.2, P < 0.01) and reduced severity of local adverse events (Δ LSR = −1.4, P < 0.01) than c‐ PDT . Increasing outdoor temperature was associated with the efficacy of DL ‐ PDT and the severity of adverse events. DL ‐ PDT was preferred by 88% of the patients. Conclusion MAL DL‐PDT showed similar efficacy to c‐ PDT in the treatment of AK I of the face/scalp but was less effective than c‐ PDT for AK s II and III . DL ‐ PDT was better tolerated being associated with lower pain and occurrence of fewer adverse events. Clinical response to DL ‐ PDT was significantly moderated by outdoor temperature, increasing at higher temperatures.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom